Ryan Lewis+FollowSkipping Cancer Surgery? This Is HugeDid you see this? A new study found that some people with early-stage cancers (like rectal or colon) might be able to ditch surgery altogether and just use immunotherapy. 82% of patients on Jemperli had no signs of cancer after 6 months—most skipped surgery and kept their organs! It works best for tumors with a thing called dMMR, so if you or someone you know is dealing with this, ask the doc about it. Imagine beating cancer without going under the knife! #CancerResearch #Immunotherapy #MedicalBreakthrough #Jemperli #HealthNews #Health180Share
Jacqueline Howard DDS+FollowGame-Changer for Aggressive Colon CancerBig news for folks battling BRAF V600E-mutated metastatic colorectal cancer: the FDA just approved a new combo—Braftovi + Erbitux + chemo—as a first-line treatment! The BREAKWATER trial showed this mix bumps response rates up to 60% (vs. 40% with chemo alone). Translation: more patients are seeing their tumors shrink and feeling better, faster. If you or someone you know is dealing with this tough cancer, this could be a real lifeline. Testing for the BRAF mutation early is now more important than ever! #CancerResearch #FDAApproval #ColorectalCancer #BRAFMutation #MedicalBreakthrough #Health411Share
Aaron Rodriguez+FollowRare Cancer Drug Gets Fast Track NodBig news for anyone following cancer breakthroughs: the FDA just gave Fast Track status to givinostat, a potential game-changer for people with polycythemia vera (PV), a rare blood cancer with few treatment options. This means the drug could reach patients faster if trials go well. Givinostat targets the root cause of PV and could help control symptoms and lower the risk of serious complications. Fingers crossed for the Phase III trial! #CancerResearch #FDA #RareDisease #MedicalBreakthrough #PolycythemiaVera #Health2325Share
April Anderson+FollowGame-Changer for Tough Lymphomas?Just read about a new treatment combo that could seriously boost survival for people with aggressive T- and NK-cell lymphomas. Researchers found that using small-molecule inhibitors first, then epigenetic modifiers, worked way better than old-school chemo for those who relapsed. The difference was especially huge for high-risk patients! It’s wild how switching up the order of meds could make such a big impact. Could this be the new standard for tough-to-treat blood cancers? #CancerResearch #Lymphoma #MedicalBreakthrough #Oncology #HealthNews #Health20Share
Kristi Key+FollowGene Therapy Breakthrough for ThalassemiaDid you know gene therapy is actually changing lives for people with beta-thalassemia? Docs at CHOP just shared real-world results with beti-cel (Zynteglo), and patients are finally ditching those constant blood transfusions. The catch? Some need more platelet support, but overall, it’s a game-changer. Experts say these new therapies are not just effective—they’re curative for thalassemia and even sickle cell. Feels like we’re witnessing a medical revolution! #GeneTherapy #Thalassemia #MedicalBreakthrough #Healthcare #BloodDisorders #Health00Share
Michelle Welch+FollowBladder Cancer Breakthrough? Read ThisBladder cancer treatments have barely changed in decades, but a new therapy called cretostimogene grenadenorepvec is shaking things up. Instead of removing your whole bladder (which is life-altering), this treatment targets and destroys cancer cells while boosting your immune system. Early trials show promising results—over 75% of patients had a complete response, and side effects were mild. If this gets FDA approval, it could mean fewer surgeries and a much better quality of life for thousands. Major hope for NMIBC patients! #BladderCancer #MedicalBreakthrough #CancerResearch #HealthNews #Innovation #Health40Share
Allison Bauer+FollowGame-Changer for Lymphoma Treatment!Big news for mantle cell lymphoma patients: the EU just approved a new combo therapy with acalabrutinib, bendamustine, and rituximab as a first-line treatment! This means older patients who can’t get stem cell transplants now have a shot at better outcomes—16+ months longer progression-free survival compared to standard chemo. The trial showed higher response rates too. It’s not a cure, but it’s a much-needed win for a tough cancer. Science for the win! #Lymphoma #CancerResearch #MedicalBreakthrough #HealthcareNews #Health313Share
john24+FollowTB Vaccine’s Wild Cancer-Fighting TwistDid you know the TB vaccine might actually help fight bladder cancer? Researchers in Spain found that a new version of the vaccine, RUTI, helped keep bladder cancer from coming back in patients—like, all of them in the test group were tumor-free after five years! The usual BCG treatment for bladder cancer already comes from the TB vaccine, but this new approach could be a game-changer. More research is needed, but this could mean way better outcomes for bladder cancer patients. #HealthNews #CancerResearch #BladderCancer #MedicalBreakthrough #Science #Health482Share
Michael Flores+FollowNew Molecule Could Change Rare Disease GameScientists just found a single molecule that might actually reverse the effects of rare, devastating genetic diseases caused by POLG mutations. This is huge—these conditions are tough to treat and can show up at any age. The new compound, PZL-A, basically helps the cell’s powerhouses (mitochondria) fix themselves, even when their DNA is messed up. Early lab results are super promising, and clinical trials are already underway. Could this be the breakthrough so many have been waiting for? #ScienceNews #MedicalBreakthrough #Genetics #RareDisease #HealthInnovation #Science90Share
john24+FollowCRISPR T-Cells Just Scored a Win!Scientists just used CRISPR to edit immune cells (TILs) for the first time in people with tough-to-treat GI cancers—and it’s actually working! One patient with advanced colorectal cancer has been cancer-free for over 21 months. This could be a game-changer for folks who don’t respond to regular immunotherapy. The future of cancer treatment is getting wild! #CRISPR #CancerResearch #Immunotherapy #MedicalBreakthrough #ScienceNews #Health150Share